Monday, May 22, 2017 8:22:04 AM
Go and read post #4999. The problem with you is you think you are the smartest one out here. Everyone has done their DD. No one blindly invests their hard earned money unless they believe in the company...I am long and don't expect quick bucks. I honestly believe PSTIs product is superior to Neupogen for ARS. The only advantage Neupogen has over PLX maybe the cost. However doesn't administering Neupogen require determining radiation levels through tests. Lets say the cost per test is X dollars . For 1 million people hope you can do the math.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM